Insight Molecular Diagnostics Inc. Accounts Payable and Other Accrued Liabilities, Current
Insight Molecular Diagnostics Inc. (IMDX) had Accounts Payable and Other Accrued Liabilities, Current of $1.00 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Payables and Accruals
us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent · last filed 2026-08-10
- 2026-06-30: Accounts Payable and Other Accrued Liabilities, Current $1.00M.
- 2026-03-31: Accounts Payable and Other Accrued Liabilities, Current $1.28M.
- 2025-12-31: Accounts Payable and Other Accrued Liabilities, Current $939.00K.
- 2025-09-30: Accounts Payable and Other Accrued Liabilities, Current $602.00K.
| Period end | Accounts Payable and Other Accrued Liabilities, Current | Accounts Payable and Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.00M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $1.28M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $939.00K 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $602.00K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $571.00K 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $1.93M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $418.00K 10-K · filed 2026-03-26 | |
| 2024-09-30 | $985.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $379.00K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $741.00K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $452.00K 10-K · filed 2025-03-24 | |
| 2023-09-30 | $826.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $2.20M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $2.37M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $1.82M 10-K · filed 2024-04-16 | $3.84M 10-K · filed 2023-04-12 |
| 2022-09-30 | $3.81M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $4.56M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $3.26M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $2.08M 10-K · filed 2023-04-12 | $2.42M 10-K · filed 2022-03-11 |
| 2021-09-30 | $1.87M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $1.93M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $5.26M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $2.28M 10-K · filed 2022-03-11 | $5.75M 10-K · filed 2021-03-19 |
| 2020-09-30 | $5.12M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $3.82M 10-Q · filed 2020-07-29 | |
| 2020-03-31 | $3.42M 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $2.61M 10-K · filed 2021-03-19 | |
| 2019-09-30 | $1.85M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $2.49M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $1.96M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $2.11M 10-K · filed 2020-03-26 | |
| 2018-09-30 | $1.04M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $1.04M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $1.91M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $1.04M 10-K · filed 2019-04-01 | $406.00K 10-K · filed 2018-04-02 |
| 2016-12-31 | $248.00K 10-K · filed 2018-04-02 | |
| 2016-09-30 | $366.00K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $346.00K 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $797.00K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $857.00K 10-K · filed 2017-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |